122 related articles for article (PubMed ID: 28695683)
1. Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma.
Lin WR; Hsu CW; Yeh CS; Chen YC; Chang ML; Liang KH; Lin CC; Chu YD; Yeh CT
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e54-e63. PubMed ID: 28695683
[TBL] [Abstract][Full Text] [Related]
2. A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma.
Yeh CT; Liang KH; Lin CC; Chang ML; Hsu CL; Hung CF
Int J Cancer; 2014 Mar; 134(5):1214-24. PubMed ID: 23959947
[TBL] [Abstract][Full Text] [Related]
3.
Chu YD; Liu HF; Chen YC; Chou CH; Yeh CT
Front Oncol; 2022; 12():996820. PubMed ID: 36530994
[TBL] [Abstract][Full Text] [Related]
4. A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy.
Lin CC; Hsu CW; Chen YC; Chang ML; Liang KH; Lai MW; Lin CL; Chien RN; Lin KH; Yeh CT
Pharmacogenomics J; 2020 Feb; 20(1):57-68. PubMed ID: 31611591
[TBL] [Abstract][Full Text] [Related]
5. GALNT14 SNP as a potential predictor of response to combination chemotherapy using 5-FU, mitoxantrone and cisplatin in advanced HCC.
Liang KH; Lin CC; Yeh CT
Pharmacogenomics; 2011 Jul; 12(7):1061-73. PubMed ID: 21635146
[TBL] [Abstract][Full Text] [Related]
6. Rs9679162 genotype predicts prognosis of real-world advanced hepatocellular carcinoma treated by sorafenib.
Lin CL; Chien RN; Chen LW; Chu YD; Yeh CT
Cancer Biomark; 2023; 36(3):251-266. PubMed ID: 36938726
[TBL] [Abstract][Full Text] [Related]
7. GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells.
Chu YD; Fan TC; Lai MW; Yeh CT
Cell Death Dis; 2022 Nov; 13(11):956. PubMed ID: 36376274
[TBL] [Abstract][Full Text] [Related]
8.
Lin WR; Hsu CW; Chen YC; Chang ML; Liang KH; Huang YH; Yeh CT
Mol Clin Oncol; 2014 Jul; 2(4):630-640. PubMed ID: 24940508
[TBL] [Abstract][Full Text] [Related]
9. GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
Lin WR; Chiang JM; Liang KH; Lim SN; Lai MW; Tsou YK; Hsieh TY; Hsu CK; Yeh CT
Medicine (Baltimore); 2016 Apr; 95(17):e3487. PubMed ID: 27124048
[TBL] [Abstract][Full Text] [Related]
10. GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial.
Chen WT; Lin SM; Lee WC; Wu TJ; Lin CC; Shen CH; Chang ML; Lin CL; Yeh CT
Hepatol Int; 2022 Feb; 16(1):148-158. PubMed ID: 34982369
[TBL] [Abstract][Full Text] [Related]
11. Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.
Lee HL; Cheng HL; Liu YF; Chou MC; Yang SF; Chou YE
PLoS One; 2017; 12(4):e0176141. PubMed ID: 28426730
[TBL] [Abstract][Full Text] [Related]
12. Genotyping the
Liang KH; Yang PC; Yeh CT
Oncol Lett; 2014 Nov; 8(5):2215-2220. PubMed ID: 25295111
[TBL] [Abstract][Full Text] [Related]
13. GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Liang KH; Lin CL; Chen SF; Chiu CW; Yang PC; Chang ML; Lin CC; Sung KF; Yeh C; Hung CF; Chien RN; Yeh CT
Pharmacogenomics; 2016 Mar; 17(4):353-66. PubMed ID: 26871639
[TBL] [Abstract][Full Text] [Related]
14. IL-28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
Terashima T; Honda M; Toyama T; Shimakami T; Shimizu R; Takatori H; Arai K; Kawaguchi K; Kitamura K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
J Gastroenterol Hepatol; 2020 Oct; 35(10):1813-1820. PubMed ID: 32180251
[TBL] [Abstract][Full Text] [Related]
15. Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer.
Schirmer MA; Lüske CM; Roppel S; Schaudinn A; Zimmer C; Pflüger R; Haubrock M; Rapp J; Güngör C; Bockhorn M; Hackert T; Hank T; Strobel O; Werner J; Izbicki JR; Johnsen SA; Gaedcke J; Brockmöller J; Ghadimi BM
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26857392
[TBL] [Abstract][Full Text] [Related]
16. MDR1 gene polymorphism correlated with pathological characteristics and prognosis in patients with primary hepatocellular carcinoma receiving interventional therapy.
Hu W; Huang S; Dong L; Yu C; Li C; Zhang J
Anticancer Drugs; 2019 Mar; 30(3):233-240. PubMed ID: 30779721
[TBL] [Abstract][Full Text] [Related]
17. A long non-coding RNA TSLD8 inhibits hepatocellular carcinoma by stabilizing WWOX.
Xu F; Wang B; Liu M; Liu T; Zhang R
Biochem Biophys Res Commun; 2019 Aug; 516(2):526-532. PubMed ID: 31230746
[TBL] [Abstract][Full Text] [Related]
18. Association of rs9679162 Genetic Polymorphism and Aberrant Expression of Polypeptide
Lin NC; Shih YH; Chiu KC; Li PJ; Yang HW; Lan WC; Hsia SM; Wang TH; Shieh TM
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077753
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
[TBL] [Abstract][Full Text] [Related]
20. Relationship of genetic variant distributions of WW domain-containing oxidoreductase gene with uterine cervical cancer.
Lin YH; Hsiao YH; Wu WJ; Yang SF; Hsu CF; Kang YT; Wang PH
Int J Med Sci; 2018; 15(10):1005-1013. PubMed ID: 30013442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
